India's
Matrix Laboratories buys 95.51 percent of Belgian Generic Drug Distributor
05 October, 2005
India's Matrix Laboratories has acquired 95.51
percent of Belgian generic
drugs distributor Docpharma through an agreed takeover bid and
now plans to acquire the remaining shares via a squeeze-out.
Docpharma and Matrix said in a statement that the
squeeze-out bid will run from Oct. 12, 2005 until Nov. 2, 2005.
Matrix will offer 34 euros per share, valuing the entire company
at about 220 million euros ($262 million). Shares in Docpharma were
suspended on Tuesday pending the statement. On Monday the shares
closed at 33.50 euros each.
The Indian drug maker had earlier already purchased
around 22 percent of Docpharma from previous owners and company
founders, the Van Rompay family, also paying 34 euros per share.
To read more:
http://asia.news.yahoo.com/051005/3/28dxu.html
